CME CirclePrint this Activity for Offline ReferenceInstructions on Taking Medscape CME

Bacteremia Due to Staphylococcus aureus: Acquisition, Methicillin Resistance, and Treatment Issues CME/CE
Faculty: Andrew F. Shorr, MD, MPH; William L. Jackson, MD
Disclosures

Release Date: October 20, 2004; Valid for credit through October 20, 2005

This activity has expired.
CME in this activity indicates that it was developed according to ACCME guidelines and was certified for credit by one or more accredited CME or CE providers. Medscape cannot attest to the timeliness of expired CME activities.


This CME activity "Bacteremia Due to Staphylococcus aureus: Acquisition, Methicillin Resistance, and Treatment Issues" was originally offered as a monograph certified for CME.

Contents of This CME/CE Activity
  1. Bacteremia Due to Staphylococcus aureus: Acquisition, Methicillin Resistance, and Treatment Issues
    by Andrew F. Shorr, MD, MPH; William L. Jackson, MD
    Introduction
    Evolving Importance of Methicillin Resistance
    Healthcare-Related S aureus Bacteremia: A Unique Disease
    Is Methicillin-Resistant S Aureus Infection Worse?
    New Issues in Treatment
    Conclusions
    References

These educational activities, certified by accredited providers, were not prepared by Medscape's editors, but are made available on our site as a service to our audience. Authors are routinely instructed by the provider to disclose significant financial relationships and mention of investigational drugs and unapproved indications. Medscape has received a fee for posting these activities. Direct questions or comments to: CME@webmd.net.

 
Legal Disclaimer
The materials presented here do not necessarily reflect the views of Medscape, AKH Inc., the companies providing educational grants or the authors and writers. These materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. All readers and continuing education participants should verify all information and consult a qualified healthcare professional before treating patients or utilizing any therapeutic product discussed in this educational activity.

 
Copyright © 2004 AKH Inc.
Pfizer
  • This activity has expired.

    The accredited provider can no longer issue certificates for this activity. Medscape cannot attest to the timeliness of expired CME activities.

  • CME/CE Information
 
AKH Inc.
AKH Inc. is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

AKH Inc. designates this educational activity for a maximum of 1.0 category 1 credit toward the AMA Physician's Recognition Award. Each physician should claim only those credits that he/she actually spent in the activity.

Contact This Provider

AKH Inc. is accredited as a provider of continuing education in nursing by the American Nurses Credentialing Center (ANCC) and through the boards of nursing in CA#: CEP12070 and IA#: 277. This course is designed to meet the criteria for all state boards of nursing requiring continuing education.

This educational activity is for 1.2 contact hours (0.12 CEU).

Contact This Provider

ACPE logoAKH Inc. is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This program has been assigned the Universal Program Number UPN# 077-999-04-031-H01 and is acceptable for 1.0 contact hours (0.1 CEUs) in states that recognize ACPE-approved providers.

Contact This Provider

All material on this website is protected by copyright, Copyright © 1994-2008 by Medscape. This website also contains material copyrighted by 3rd parties.